Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaoju,Li ^[1] ; Qianqian,Yu ^[2] ; Runze,Zhao ^[1] ; Xinyan,Guo ^[1] ; Chenlin,Liu ^[1] ; Kuo,Zhang ^[1] ; Wangqian,Zhang ^[1] ; Jinghan,Liu ^[1] ; Jinzheng,Yu ^[1] ; Shuning,Wang ^[1] ; Qiang,Hao ^[1] ; Weina,Li ^[1] ; Wei,Zhang ^[1] ; Meng,Li ^[1] ; Yingqi,Zhang ^[1] ; Cun,Zhang ^[1] ; Yuan,Gao ^[1]

作者单位： State Key Laboratory of Cancer Biology, Biotechnology Center, School of Pharmacy, The Fourth Military Medical University, Xi'an, China. ^[1] Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ^[2]

关键词 engineered exosome ferroptosis hepatocellular carcinoma resistance sorafenib

DOI 10.3389/fonc.2022.898156

PMID 35814401

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2022年12卷

898156页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Designer Exosomes for Targeted Delivery of a Novel Therapeutic Cargo to Enhance Sorafenib-Mediated Ferroptosis in Hepatocellular Carcinoma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除